Thats why our approach is deeply personalized
An RCT in patients with cirrhosis, hyperammonemia, and hypozincemia ( ~150-250 uM (depending on clinical context
These indications are being actively studied, and additional FDA approvals for non-weight-loss uses are anticipated over the next few years
Agents that bind to the glucagon-like peptide-1 receptor are called GLP-1 agonists and are useful in treating type 2 diabetes
Suboptimal gastrointestinal health can impair nutrient absorption and hormone regulation, liver dysfunction can lead to the inadequate clearance of hormone metabolites, and adrenal fatigue can exacerbate symptoms of hormonal imbalance by disrupting cortisol and other hormone levels
The peptides discussed by the advisory committee were formerly identified by the FDA as posing significant safety risks, and the vote to loosen restrictions has stirred controversy in medical circles